Apogee Therapeutics Inc. (APGE)

NASDAQ: APGE · Real-Time Price · USD

39.26

0.01 (0.03%)

At close: May 01, 2025, 3:59 PM

39.20

-0.15%

Pre-market: May 02, 2025, 06:20 AM EDT

Apogee Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-182.15M	-83.98M	-39.78M
Depreciation & Amortization	189K	n/a	n/a
Stock-Based Compensation	23.33M	6.1M	2.14M
Other Working Capital	-930K	4.49M	9.4M
Other Non-Cash Items	-10.55M	-2.98M	11.4M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-2M	6.11M	9.81M
Operating Cash Flow	-171.17M	-74.76M	-16.43M
Capital Expenditures	-1.15M	-167K	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-649.45M	-303.74M	n/a
Sales Maturities Of Investments	350.14M	30M	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	-300.46M	-273.91M	n/a
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	1.63M	n/a	183.62K
Financial Cash Flow	495.11M	315.39M	183.62K
Net Cash Flow	23.47M	-33.28M	-16.24M
Free Cash Flow	-172.33M	-74.93M	-16.43M